SR9009

Description

Product Overview:
– Name: [Common Name or IUPAC Name]
– CAS No.: 841205-47-8
– Molecular Weight: 389.33 g/mol
– Chemical Formula: C₁₉H₁₄F₃N₃O₃

Dosage and Contents:
– Total Volume: 50 ml
– Concentration: 25 mg/ml
– Total Active Ingredient: 50 x 25 mg (total 1250 mg)

Chemical Properties:
– Solubility: Soluble in polyglycols, indicating compatibility with specific solvents.
– Purity: >99%, ensuring high quality and minimal contamination.

Storage Conditions:
– Recommended Storage Temperature: Store at 20°C.
– Shelf Life: 2 years from the date of manufacture, given proper storage.

Pharmacokinetics:
– Half-Life: 24 hours, indicating duration of action and frequency of administration.

Additional Information:
– Ensure proper labeling and handling as per safety guidelines.
– Use only for intended applications and adhere to recommended dosages for safety and efficacy.

This formulation is suitable for both research and clinical applications where a stable compound with reliable potency and solubility characteristics is required.

L’ingrediente menzionato nella descrizione è Ostarine (MK-2866), che è noto come modulatore selettivo del recettore degli androgeni (SARM). Ecco alcune referenze scientifiche che ho trovato su questa sostanza:

1. Basaria, S., Collins, L., Dillon, E. L., Orwoll, K., Storer, T. W., Miciek, R., Ulloor, J., Zhang, A., Eder, R., Zientek, H., Gordon, G., Kazmi, S., Sheffield-Moore, M., & Bhasin, S. (2013). The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men. The Journals of Gerontology: Series A, 68(1), 87–95. https://doi.org/10.1093/gerona/gls078
2. Singh, R., Bhasin, S., Braga, M., Artaza, J. N., Pervin, S., Taylor, W. E., Krishnan, V., Sinha, S.K., Rajavashisth, T. B., & Jasuja, R. (2009). Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways. Endocrinology, 150(3), 1259–1268. https://doi.org/10.1210/en.2008-0858
3. Gao, W., Kim, J., Dalton, J.T. (2006). Pharmacokinetics and Pharmacodynamics of Nonsteroidal Androgen Receptor Ligands. Pharmaceutical Research, 23 (8) , 1641-1658. https://doi.org/10.1007/s11095-006-9024-8
4. Chen, J., Kim, J., Dalton, J. T. (2005). Discovery